Meloxicam Inhibits Hepatocellular Carcinoma Progression and Enhances the Sensitivity of Immunotherapy via the MicroRNA-200/PD-L1 Pathway.
Sun GuangshunSun GuoqiangChen XinKong XiangyiZheng WubinLi ZhitaoZheng ZhiyingHongyong CaoLv ChengyuYongxiang XiaWeiwei TangPublished in: Journal of oncology (2022)
Our study showed meloxicam inhibited HCC progression and enhanced the sensitivity of immunotherapy via the microRNA-200/PD-L1 pathway.
Keyphrases